PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION

被引：0
|
作者：
Eng, G. [1 ,2 ]
Fana, V. [3 ]
Omerovic, E. [4 ]
Hojsgaard, P. [5 ]
Lindegaard, H. M. [6 ]
Jensen, E. K. [7 ]
Bouchelouche, P. N. [1 ]
机构：
[1] Copenhagen Univ Hosp Koge, Koge, Region Zealand, Denmark
[2] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Dept Rheumatol, Parker Inst, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Glostrup, Denmark
[4] Copenhagen Univ Hosp Frederiksberg & Bispebjerg, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Gentofte, Denmark
[6] Odense Univ Hosp, DK-5000 Odense, Denmark
[7] Copenhagen Univ Hosp Holbaek, Holbaek, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [31] A novel method for the detection of antibodies to adalimumab in the presence of drug reveals "hidden" immunogenicity in rheumatoid arthritis patients
    van Schouwenburg, Pauline A.
    Bartelds, Geertje M.
    Hart, Margreet H.
    Aarden, Lucien
    Wolbink, Gerrit Jan
    Wouters, Diana
    JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 362 (1-2) : 82 - 88
  • [32] Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with longterm infliximab therapy
    Comby, E
    Tanaff, P
    Mariotte, D
    Costentin-Pignol, V
    Marcelli, C
    Ballet, JJ
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 24 - 30
  • [33] Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis
    Siljehult, F.
    Arlestig, L.
    Eriksson, C.
    Rantapaa-Dahlqvist, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (05) : 345 - 350
  • [34] Drug-survival, effectiveness and safety of infliximab, adalimumab and etanercept in rheumatoid arthritis patients
    Flendrie, M.
    Creemers, M. C. W.
    Welsing, P. M. J.
    Van den Hoogen, F. H. J.
    Van Riel, P. L. C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 191 - 191
  • [35] Cost of Etanercept, Adalimumab, and Infliximab in Patients with Rheumatoid Arthritis with Employer Provided Health Insurance
    Bonafede, Machaon
    Watson, Crystal
    Joseph, George
    Princic, Nicole
    Harrison, David J.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S778 - S778
  • [36] Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients
    Brocq, O
    Albert, C
    Roux, C
    Gerard, D
    Breuil, V
    Ziegler, LE
    JOINT BONE SPINE, 2004, 71 (06) : 601 - 603
  • [37] Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
    Neovius, M.
    Arkema, E. V.
    Olsson, H.
    Eriksson, J. K.
    Kristensen, L. E.
    Simard, J. F.
    Askling, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 354 - 360
  • [38] Incidence of Anti-Drug Antibodies in Rheumatoid Arthritis Patients Treated with Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Moots, R. J.
    Xavier, Ricardo
    Mok, Chi Chiu
    Rahman, Mahboob U.
    Tsai, Wen-Chan
    Al Maini, Mustafa
    Pavelka, Karel
    Mahgoub, Ehab
    Kotak, Sameer
    Korth-Bradley, Joan
    Pedersen, Ronald
    Mele, Linda
    Shen, Qi
    Vlahos, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [39] Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting
    Maid, Pablo J.
    Xavier, Ricardo
    Real, Rosa M.
    Pedersen, Ron
    Shen, Qi
    Marshall, Lisa
    Solano, Gaston
    Elena Borlenghi, Cecilia
    Pardo Hidalgo, Rodolfo
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 (04) : 177 - 182
  • [40] INFLIXIMAB AND ADALIMUMAB LEVELS AND ANTIDRUG ANTIBODIES DETECTION IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): AN INTERLABORATORY COMPARISON USING A COMMERCIAL ELISA ASSAY
    Valor, L.
    Florez, D. Hernandez
    de la Torre, I.
    Llinares, F.
    Rosas, J.
    Yaque, J.
    Naredo, E.
    Gonzalez, C.
    Lopez-Longo, J.
    Monteagudo, I.
    Montoro, M.
    Perez, L. Carreno
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 937 - 937
12345